Chair: @Bryan Rhodes
Scribe: @Isaac Vetter
Professional Associations, such as HL7, which bring together competing entities are subject to strict
scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote
fairness in competition and, as such, supports laws against monopoly and restraints of trade and their
enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is
responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of
the Governance and Operations Manual (GOM).
NOTE: This attendance applies if you are present at the related meeting/call, regardless if you have signed a different attendance for your WG.
|University of Utah|
Minutes Approved as Presented
This is to approve minutes via general consent. "You have received the minutes. Are there any corrections to the minutes? (pause) Hearing none, if there are no objections, the minutes are approved as printed."
Meeting Minutes from Discussion
|Decision Link(if not child)|
January 2023 Ballot Cycle (2023 January Cycle)
May 2023 Ballot Cycle
|IPA Project Update|
HL7.FHIR.UV.IPA\International Patient Access - FHIR v4.0.1
DTR Block Vote
Block-votes for CRD, DTR, and PAS were described last week. FM has approved CDR and PAS block votes. The DTR block vote has only a single Not Persuasive.
Bob Dieterle / Jeff Brown : 12-0-2
Opposed: 0, Abstain: 2, For: 12
|WGM Agenda Review|
January 2023 CDS-CQI WGM Agenda
|FHIR Tracker Dispositions|
- FHIR-39093Getting issue details... STATUS
[FHIR-39175] Keep the Citation resource - Jira (hl7.org)
[FHIR-38816] KEEP Citation as a core FHIR Resource - Jira (hl7.org)
Brian: Citation is core to EBM. Without a FHIR Citation resource, we'd need something that's not FHIR to represent a citation. It's not an up or down vote on Citation resource; rather, it's about EBM resource as FHIR or perhaps create a new/alternate "sibling" data structure with it's own management processes. Does HL7 or FHIR want to take on the creation of a new specification (product family?) and subsequent committees, etc?
This should be a conversions and decision with FMG, not just CDS.
Does the CDS WG have a recommendation for the scientific evidence representation or evidence-based medicine representation in FHIR?
Working through this list of jiras.
12/28 call is canceled.
12/21 may be canceled, tbd.
|Adjournment||Adjourned at 12:02 Central|